Table 3.
Clinical and Laboratory Characteristics of the Adults Living with HIV in South Gondar Zone Northwest Ethiopia, 2017 (n=746)
| Baseline Clinical and Laboratory Variables | Categories | Total (%) | Censored (n, %) | Death (102) (n, %) | Long Rank p-value | Chi-square |
|---|---|---|---|---|---|---|
| Weight at baseline | Wt. ≤40 kg | 61 (8.18) | 27 (3.62) | 34 (4.56) | 0.001 | 12.92 |
| Wt. >40 kg | 685 (91.82) | 617 (82.71) | 68 (9.12) | |||
| Functional status | Working | 542 (72.65) | 499 (66.8%) | 43 (5.76) | 0.117 | 2.44 |
| Ambulatory | 133 (17.83) | 108 (14.48) | 25 (3.35) | |||
| Bed ridden | 71 (9.52) | 37 (4.95) | 34 (4.55) | |||
| WHO clinical stage | Stage I | 248 (33.24) | 225 (30.16) | 23 (3.08) | 0.01 | 46.39 |
| Stage II | 91 (12.20) | 88 (11.80) | 3 (0.40) | |||
| Stage III | 277 (37.13) | 240 (32.17) | 37 (4.96) | |||
| Stage IV | 130 (17.43) | 91 (12.20) | 39 (5.23) | |||
| CD4 baseline | <350 | 250 (27.48) | 110 (14.75) | 95 (12.73) | 0.001 | 36.89 |
| 350–500 | 236 (31.64) | 231 (30.97) | 5 (0.67) | |||
| ≥501 | 305 (40.88) | 303 (40.62) | 2 (0.27) | |||
| Chemoprophylaxis given | Yes | 546 (73.19) | 465 (62.33) | 81 (10.86) | 0.652 | 0.20 |
| No | 200 (26.81) | 179 (23.99) | 21 (2.82) | |||
| ART regiment | 1a (30) | 124 (16.62) | 102 (1.67) | 22 (2.95) | 0.062 | 11.99 |
| 1a (40) | 52 (6.97) | 42 (5.63) | 10 (1.34) | |||
| 1b (30) | 110 (14.75) | 88 (11.80) | 22 (2.95) | |||
| 1b (40) | 180 (24.13) | 161 (21.58) | 19 (2.55) | |||
| 1c | 159 (21.31) | 144 (19.30) | 15 (2.01) | |||
| 1d | 120 (16.09) | 106 (14.21) | 14 (1.88) |